Human Genome Sciences’ Fourth Quarter Solid; Preps ABthrax To Ship, Plots Revenue Spike
This article was originally published in The Pink Sheet Daily
Executive Summary
$165 million anthrax deal with feds will fund pipeline’s Albuferon for hepatitis C and more.
You may also be interested in...
HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.
HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.
Vytorin, Zetia, Other Combos In Spotlight At ACC Conference
Highlights of the upcoming American College of Cardiology conference include ENHANCE data and updates on ACCOMPLISH and ONTARGET trials.